KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Short-Term Debt issuances (2016 - 2025)

Chemed (CHE) has 17 years of Short-Term Debt issuances data on record, last reported at $10.4 million in Q4 2025.

  • For Q4 2025, Short-Term Debt issuances changed N/A year-over-year to $10.4 million; the TTM value through Dec 2025 reached $11.0 million, up 169.66%, while the annual FY2025 figure was $11.0 million, 169.66% up from the prior year.
  • Short-Term Debt issuances reached $10.4 million in Q4 2025 per CHE's latest filing, up from $301000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $10.4 million in Q4 2025 and bottomed at -$17.4 million in Q4 2022.
  • Average Short-Term Debt issuances over 5 years is -$688833.3, with a median of $86000.0 recorded in 2025.
  • Peak YoY movement for Short-Term Debt issuances: plummeted 297.27% in 2022, then surged 120.71% in 2025.
  • A 5-year view of Short-Term Debt issuances shows it stood at $8.8 million in 2021, then tumbled by 297.27% to -$17.4 million in 2022, then soared by 97.51% to -$433000.0 in 2023, then crashed by 3048.73% to -$13.6 million in 2024, then soared by 175.99% to $10.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt issuances were $10.4 million in Q4 2025, $301000.0 in Q3 2025, and -$129000.0 in Q2 2025.